1-20 of 113
Mary Eapen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Initial Results from the BEACON Clinical Study: A Phase 1/2 Study Evaluating the Safety and Efficacy of a Single Dose of Autologous CD34+ Base Edited Hematopoietic Stem Cells (BEAM-101) in Patients with Sickle Cell Disease with Severe Vaso-Occlusive Crises

Ashish O. Gupta, Akshay Sharma, Haydar Frangoul, Jignesh Dalal, Julie Kanter, Asif Alavi, John DiPersio, Mary Eapen, Jennifer J. Jaroscak, Ernesto Ayala, Edward D. Ziga, Stacey Rifkin-Zenenberg, Alex C. Minella, Guo Chen, Yinzhong Chen, Priya S. Chockalingam, Ling Lin, Marcelyne Joseney-Antoine, Leanne Ianniello, Beth Gardner, Adam J. Hartigan, Giuseppe Ciaramella, Sunita Goyal, Amy Simon, Alexis Thompson, Matthew M. Heeney
Journal: Blood
Blood (2024) 144 (Supplement 1): 513.
https://doi.org/10.1182/blood-2024-204888
Published: 2024
Journal Articles

One’s expectations for normality

Mary Eapen
Journal: Blood
Blood (2024) 144 (14): 1469–1470.
https://doi.org/10.1182/blood.2024025822
Published: 2024
Journal Articles

Choosing donors in clinical practice

Mary Eapen
Journal: Blood
Blood (2024) 144 (3): 248–249.
https://doi.org/10.1182/blood.2024024970
Published: 2024
Journal Articles

Reduced Intensity Haploidentical Bone Marrow Transplantation in Adults with Severe Sickle Cell Disease: BMT CTN 1507

Adetola A. Kassim, Mark C. Walters, Mary Eapen, Nicole Ritzau, Madoc Smith, Melhem M. Solh, Christopher McKinney, Michael Nieder, Maureen Ross, Michael Kent, Ghada Abusin, Kanwaldeep K. Mallhi, Jorge Galvez Silva, Paul Shaughnessy, Julie Kanter, Hilary Haines, Rafic J Farah, Yasser Khaled, Allistair Abraham, Catherine M. Bollard, Kenneth R. Cooke, Josu de La Fuente, Rabi Hanna, Mary M. Horowitz, Lori C Jordan, Lakshmanan Krishnamurti, Eric Leifere, Kris Michael Mahadeo, Shalini Shenoy, Nicole M. Ritzau, Michael R. DeBaun, Robert A. Brodsky
Journal: Blood
Blood (2023) 142 (Supplement 2): LBA-4.
https://doi.org/10.1182/blood-2023-192022
Published: 2023
Journal Articles

Long-Term Outcomes after Unrelated Marrow Transplantation for Aplastic Anemia with Optimized Cyclophosphamide Dose (BMT CTN 0301)

Mary Eapen, Joseph Antin, Jakub Tolar, Sally Arai, Mitchell Horwitz, Jainqun Kou, Eric Leifere, John M. McCarty, Ryotaro Nakamura, Michael A. Pulsipher, Mary M. Horowitz, H Joachim Deeg
Journal: Blood
Blood (2023) 142 (Supplement 1): 235.
https://doi.org/10.1182/blood-2023-178093
Published: 2023
Journal Articles

Gene Therapy Expressing Platelet-Derived Factor VIII for Correction of Hemophilia Α with a History of Inhibitors

David A. Wilcox, Myriam Armant, Lynn Malec, Qizhen Shi, Bryon D. Johnson, Huiqing Xu, Lily M. Du, Lisa J. Duffy, Frederic D. Bushman, James H. Jerkins, Peiman Hematti, Ruta Brazauskas, Shawn M. Jobe, Parameswaran N. Hari, Mary Eapen
Journal: Blood
Blood (2023) 142 (Supplement 1): 2249.
https://doi.org/10.1182/blood-2023-172845
Published: 2023
Journal Articles

To treat with curative intent or modify disease?

Clinical Trials & Observations
Mary Eapen
Journal: Blood
Blood (2023) 141 (1): 4–5.
https://doi.org/10.1182/blood.2022017792
Published: 2023
Journal Articles

Impact of Center Experience with Donor Type and Treatment Platform on Outcomes: A Secondary Analysis BMT CTN 1101

Claudio G. Brunstein, Paul V O'Donnell, Brent R. Logan, Luciano J. Costa, Corey Cutler, Michael Craig, William J Hogan, Mary M. Horowitz, Mitchell E. Horwitz, Chatchada Karanes, John M. Magenau, Adriana Malone, John M McCarty, Joseph P. McGuirk, Lawrence E Morris, Andrew R. Rezvani, Witold Rybka, Rachel Salit, Sumithira Vasu, Mary Eapen, Ephraim J. Fuchs
Journal: Blood
Blood (2021) 138 (Supplement 1): 3956.
https://doi.org/10.1182/blood-2021-145527
Published: 2021
Journal Articles

Peri-Transplant Alemtuzumab Levels Predict Risk of Secondary Graft Failure and Inversely Impact CXCL9 Levels after RIC HCT (A Correlative Biology Study to BMT-CTN 1204 RICHI)

Ashley V Geerlinks, Brooks Scull, Christa Krupski, Ryan Fleischmann, Michael A. Pulsipher, Mary Eapen, Jim A. Connelly, Catherine M. Bollard, Sung-Yun Pai, Christine N. Duncan, Leslie S Kean, K. Scott Baker, Lauri S Burroughs, Jeffrey R. Andolina, Michael B Jordan, Tsz-Kwong Man, Carl E. Allen, Rebecca A. Marsh
Journal: Blood
Blood (2021) 138 (Supplement 1): 748.
https://doi.org/10.1182/blood-2021-145629
Published: 2021
Journal Articles

Long-Term Survival and Late Death after Hematopoietic Cell Transplant for Patients with Sickle Cell Disease Surviving for at Least Two-Years after Transplantation

Andrew St. Martin, Kyle Hebert, Arnaud Serret-Larmande, Vianney Jouhet, Emily Hughes, Jason Paul Stedman, Thomas DeSain, Danielle Pillon, Jessica Lyons Carpenter, Patricia Steinert, Paul Avillach, Mary Eapen
Journal: Blood
Blood (2021) 138 (Supplement 1): 410.
https://doi.org/10.1182/blood-2021-150912
Published: 2021
Journal Articles

HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis

Mahasweta Gooptu, Rizwan Romee, Andrew St. Martin, Mukta Arora, Monzr Al Malki, Joseph H. Antin, Christopher N. Bredeson, Claudio G. Brunstein, Saurabh Chhabra, Ephraim J. Fuchs, Nilanjan Ghosh, Michael R. Grunwald, Christopher G. Kanakry, Natasha Kekre, Jospeh P. McGuirk, Ian K. McNiece, Rohtesh S. Mehta, Marco Mielcarek, Fillipo Milano, Dipenkumar Modi, Ran Reshef, Scott R. Solomon, Mark A. Schroeder, Edmund K. Waller, Yoshiro Inamoto, Robert J. Soiffer, Mary Eapen
Journal: Blood
Blood (2021) 138 (3): 273–282.
https://doi.org/10.1182/blood.2021011281
Published: 2021
Journal Articles

A validated pediatric disease risk index for allogeneic hematopoietic cell transplantation

CME
Muna Qayed, Kwang Woo Ahn, Carrie L. Kitko, Mariam H. Johnson, Nirali N. Shah, Christopher Dvorak, Karin Mellgren, Brian D. Friend, Michael R. Verneris, Wing Leung, Jacek Toporski, John Levine, Joseph Chewning, Alan Wayne, Urvi Kapoor, Brandon Triplett, Kirk R. Schultz, Gregory A. Yanik, Mary Eapen
Journal: Blood
Blood (2021) 137 (7): 983–993.
https://doi.org/10.1182/blood.2020009342
Published: 2021
Journal Articles

Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial

Clinical Trials & Observations
Ephraim J. Fuchs, Paul V. O’Donnell, Mary Eapen, Brent Logan, Joseph H. Antin, Peter Dawson, Steven Devine, Mary M. Horowitz, Mitchell E. Horwitz, Chatchada Karanes, Eric Leifer, John M. Magenau, Joseph P. McGuirk, Lawrence E. Morris, Andrew R. Rezvani, Richard J. Jones, Claudio G. Brunstein
Journal: Blood
Blood (2021) 137 (3): 420–428.
https://doi.org/10.1182/blood.2020007535
Published: 2021
Includes: Supplemental data
Journal Articles

Conditioning Regimens and Outcomes after Allogeneic Hematopoietic Cell Transplant for Hyperinflammatory Inborn Errors of Immunity

Rebecca A. Marsh, Soyoung Kim, Kyle Hebert, Christopher C. Dvorak, MD, Victor Aquino, MD, K. Scott Scott Baker, MD MS, Deepak Chellapandian, MD, Blachy Davila, MD, Christine Duncan, MD, Michael J. Eckrich, MD MPH, George E. Georges, MD, Timothy S. Olson, MD PhD, Michael A Pulsipher, MD, Shalini Shenoy, MD, Elizabeth Stenger, MD, Mark Vander Lugt, MD, Lolie C. Yu, MD, Andrew Gennery, MD, Mary Eapen, MBBS, MS
Journal: Blood
Blood (2020) 136 (Supplement 1): 36–37.
https://doi.org/10.1182/blood-2020-139930
Published: 2020
Journal Articles

Comparison of Outcomes after Haploidentical Relative and HLA Matched Unrelated Donor Transplantation with Post-Transplant Cyclophosphamide Containing Gvhd Prophylaxis Regimens

Mahasweta Gooptu, MD, Andrew St. Martin, MS, Rizwan Romee, MD, Mukta Arora, MD, Monzr M. Al Malki, MD, Joseph H. Antin, MD, Christopher Bredeson, MDFRCPC,MSc, Claudio G. Brunstein, MD PhD, Saurabh Chhabra, MD, Ephraim J. Fuchs, MD MBA, Nilanjan Ghosh, MD PhD, Michael R. Grunwald, MD, Yoshihiro Inamoto, MD, Christopher G. Kanakry, MD, Natasha Kekre, MD MPH, FRCPC, Joseph P. McGuirk, DO, Ian K. McNiece, PhD, Rohtesh S. Mehta, MDMPH,MS, Marco Last Mielcarek, MD, Filipo Milano, MD PhD, Dipenkumar Modi, MD, Ran Reshef, MD, Mark A. Schroeder, MD, Robert J. Soiffer, MD, Scott R. Solomon, MD, Edmund K. Waller, PhDMD, Mary Eapen, MBBS, MS
Journal: Blood
Blood (2020) 136 (Supplement 1): 21–22.
https://doi.org/10.1182/blood-2020-137221
Published: 2020
Journal Articles

Risk score to predict event-free survival after hematopoietic cell transplant for sickle cell disease

Clinical Trials & Observations Brief Report
Ruta Brazauskas, Graziana M. Scigliuolo, Hai-Lin Wang, Barbara Cappelli, Annalisa Ruggeri, Courtney D. Fitzhugh, Jane S. Hankins, Julie Kanter, Joerg J. Meerpohl, Julie A. Panepinto, Damiano Rondelli, Shalini Shenoy, Mark C. Walters, John E. Wagner, John F. Tisdale, Eliane Gluckman, Mary Eapen
Journal: Blood
Blood (2020) 136 (5): 623–626.
https://doi.org/10.1182/blood.2020005687
Published: 2020
Includes: Supplemental data
Journal Articles

A Phase II Trial to Compare Allogeneic Transplant Vs. Standard of Care for Severe Sickle Cell Disease: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 1503

Mary Eapen, MBBS, MS, Donna S Neuberg, ScD, Adam M. Mendizabal, MS, Kristen E. Stevenson, MS, Joseph H. Antin, MD, Nancy DiFronzo, PhD, Fuad A El Rassi, MD, Premal Lulla, MBBS, Edmund K. Waller, PhDMD, Jamie Garrison, Shannon Smith, MSN, Keith Sullivan, MD, Mark C. Walters, MD, Lakshmanan Krishnamurti, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4592.
https://doi.org/10.1182/blood-2019-126793
Published: 2019
Journal Articles

Reduced Intensity Conditioning for Haploidentical Bone Marrow Transplantation in Patients with Symptomatic Sickle Cell Disease: BMT CTN Protocol 1507

Adetola A. Kassim, MDMS, Mark C. Walters, MD, Mary Eapen, MBBS, MS, Brianne Allison, MS, Adam M. Mendizabal, MS, Robert A. Brodsky, MD, Michael R. DeBaun, MDMPH
Journal: Blood
Blood (2019) 134 (Supplement_1): 802.
https://doi.org/10.1182/blood-2019-126321
Published: 2019
Journal Articles

Allogeneic Transplantation for Myelodysplastic Syndrome in Adults over 50 Years Old Using Reduced Intensity/Non-Myeloablative Conditioning: Haploidentical Relative Versus Matched Unrelated Donor

Michael R. Grunwald, MD, Mei-Jie Zhang, Hany Elmariah, MDMS, Mariam H Johnson, MPH, Andrew St. Martin, MS, Asad Bashey, MD PhD, Javier Bolanos-Meade, MD, Christopher Bredeson, MDFRCPC,MSc, Edward A Copelan, Biju George, MDDM, Vikas Gupta, MD FRCP, FRCPath, Christopher G. Kanakry, MD, Rohtesh S. Mehta, MD, Minoo Battiwalla, MD, Alberto Mussetti, Ryotaro Nakamura, MD, Taiga Nishihori, MD, Wael Saber, MD MS, Melhem Solh, MD, Benjamin K. Tomlinson, MD, Daniel J. Weisdorf, MD, Mary Eapen, MBBS, MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 3323.
https://doi.org/10.1182/blood-2019-125865
Published: 2019
Journal Articles

Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR

CME
Jason Dehn, Stephen Spellman, Carolyn K. Hurley, Bronwen E. Shaw, Juliet N. Barker, Linda J. Burns, Dennis L. Confer, Mary Eapen, Marcelo Fernandez-Vina, Robert Hartzman, Martin Maiers, Susana R. Marino, Carlheinz Mueller, Miguel-Angel Perales, Raja Rajalingam, Joseph Pidala
Journal: Blood
Blood (2019) 134 (12): 924–934.
https://doi.org/10.1182/blood.2019001212
Published: 2019